Recently, Chen et al.38 released that CCL2 could act as a key target of ELF-1 contributing to the cell proliferation, migration, invasion, and drug resistance of nasopharyngeal carcinoma. The gene discussed is CCL2; the disease is nasopharyngeal carcinoma.